FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Glimepiride Tablets
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Teva Pharmaceuticals (New 05/17/2019)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
1 mg 100 Count (NDC 0093-7254-01) 05/17/2019 Teva made a business decision to discontinue this product.
2 mg 100 Count (NDC 0093-7255-01) 05/17/2019 Teva made a business decision to discontinue this product.
4 mg 100 Count (NDC 0093-7256-01) 05/17/2019 Teva made a business decision to discontinue this product.
4 mg 250 Count (NDC 0093-7256-52) 05/17/2019 Teva made a business decision to discontinue this product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English